These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19913192)

  • 21. Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidence.
    Pandey SC; Carr LG; Heilig M; Ilveskoski E; Thiele TE
    Alcohol Clin Exp Res; 2003 Feb; 27(2):149-54. PubMed ID: 12605064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors.
    Sillaber I; Rammes G; Zimmermann S; Mahal B; Zieglgänsberger W; Wurst W; Holsboer F; Spanagel R
    Science; 2002 May; 296(5569):931-3. PubMed ID: 11988580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
    Valdez GR; Koob GF
    Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the nociceptin/orphanin FQ system is unable to reverse CRF2 receptor mediated anorexia in the rat.
    Fedeli A; Policani F; Ubaldi M; Cippitelli A; Massi M; Ciccocioppo R
    Peptides; 2006 Dec; 27(12):3284-91. PubMed ID: 17050037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.
    Schreiber AL; Gilpin NW
    Handb Exp Pharmacol; 2018; 248():435-471. PubMed ID: 29374836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors regulating stress-induced alcohol-seeking and pharmacotherapeutic treatments: brief introduction and rationale.
    Lawrence AJ
    Alcohol; 2009 Nov; 43(7):545-6. PubMed ID: 19913198
    [No Abstract]   [Full Text] [Related]  

  • 27. Alcoholism: allostasis and beyond.
    Koob GF
    Alcohol Clin Exp Res; 2003 Feb; 27(2):232-43. PubMed ID: 12605072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting opioid and neurokinin-1 receptors to treat alcoholism.
    Rodriguez FD; Coveñas R
    Curr Med Chem; 2011; 18(28):4321-34. PubMed ID: 21861818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The central amygdala as an integrative hub for anxiety and alcohol use disorders.
    Gilpin NW; Herman MA; Roberto M
    Biol Psychiatry; 2015 May; 77(10):859-69. PubMed ID: 25433901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
    Heilig M
    J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
    Pickens CL; Adams-Deutsch T; Nair SG; Navarre BM; Heilig M; Shaham Y
    Neuroscience; 2009 Dec; 164(4):1398-406. PubMed ID: 19800945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic mechanisms of alcoholism and stress-related disorders.
    Palmisano M; Pandey SC
    Alcohol; 2017 May; 60():7-18. PubMed ID: 28477725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation.
    Valdez GR; Sabino V; Koob GF
    Alcohol Clin Exp Res; 2004 Jun; 28(6):865-72. PubMed ID: 15201629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of CRH in behavioral responses to stress.
    Smagin GN; Heinrichs SC; Dunn AJ
    Peptides; 2001 May; 22(5):713-24. PubMed ID: 11337084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-environment interactions resulting in risk alcohol drinking behaviour are mediated by CRF and CRF1.
    Clarke TK; Schumann G
    Pharmacol Biochem Behav; 2009 Sep; 93(3):230-6. PubMed ID: 19409922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.
    Habib KE; Weld KP; Rice KC; Pushkas J; Champoux M; Listwak S; Webster EL; Atkinson AJ; Schulkin J; Contoreggi C; Chrousos GP; McCann SM; Suomi SJ; Higley JD; Gold PW
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6079-84. PubMed ID: 10823952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress and alcohol interactions: animal studies and clinical significance.
    Spanagel R; Noori HR; Heilig M
    Trends Neurosci; 2014 Apr; 37(4):219-27. PubMed ID: 24636458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose Nociceptin/Orphanin FQ reduces anxiety-like performance in alcohol-withdrawn, but not alcohol-naïve, Male Wistar rats.
    Aujla H; Nedjadrasul D
    Neuropharmacology; 2015 Jun; 93():1-6. PubMed ID: 25617519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?
    Haass-Koffler CL
    Alcohol; 2018 Nov; 72():3-8. PubMed ID: 29510883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocircuitry of alcohol addiction: synthesis from animal models.
    Koob GF
    Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.